Pilot study of the combination of capecitabine plus oxaliplatin as adjuvant therapy for patients with stage III and high risk stage II colon cancer

被引：0
|
作者：
Olier, C. [1 ]
Reyna, C. [1 ]
Aramendia, J. M. [1 ]
Rodriguez, J. [1 ]
Viudez, A. [1 ]
Chopitea, A. [1 ]
Garcia-Foncillas, J. [1 ]
机构：
[1] Univ Navarra Clin, Pamplona, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.15093
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15093
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer
    Arnold, D.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 (02) : 196 - 197
  • [2] Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer
    Haller, Daniel G.
    Tabernero, Josep
    Maroun, Jean
    de Braud, Filippo
    Price, Timothy
    Van Cutsem, Eric
    Hill, Mark
    Gilberg, Frank
    Rittweger, Karen
    Schmoll, Hans-Joachim
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (11) : 1465 - 1471
  • [3] Efficacy and Safety of Capecitabine and Oxaliplatin (CapOX) as an Adjuvant Therapy in Japanese for Stage II/III Colon Cancer in a Group at High Risk of Recurrence in Retrospective Study
    Osawa, Hiroshi
    Handa, Naoko
    Minakata, Kunihiko
    ONCOLOGY RESEARCH, 2015, 22 (5-6) : 325 - 331
  • [4] Comparison between oxaliplatin therapy and capecitabine monotherapy for high-risk stage II-III elderly patients with colon cancer
    Park, Jueun
    Baik, HyungJoo
    Kang, Sang Hyun
    Seo, Sang Hyuk
    Kim, Kwang Hee
    Oh, Min Kyung
    Lee, Hong Sub
    Lee, Sang Heon
    Kim, Ki Hyang
    An, Min Sung
    ASIAN JOURNAL OF SURGERY, 2022, 45 (01) : 448 - 455
  • [5] MSI plus STAGE II/III COLON CANCER PATIENTS BENEFIT FROM CAPECITABINE ADJUVANT MONOTHERAPY
    Dimovski, Aleksandar
    Matevska, Nadica
    Eftimov, Aleksandar
    Nestorovska, Aleksandra Kapedanovska
    Petrusevska, Natalija Angelovska
    Angelovska, Biljana
    Jashar, Djingis
    Mitrevski, Nikola
    Josifovski, Toni
    ANNALS OF ONCOLOGY, 2012, 23 : 106 - 106
  • [6] A Feasibility Study of Capecitabine and Oxaliplatin for Patients with Stage II/III Colon Cancer -ACTOR Study-
    Suenaga, Mitsukuni
    Akiyoshi, Takashi
    Shinozaki, Eiji
    Fujimoto, Yoshiya
    Matsusaka, Satoshi
    Konishi, Tsuyoshi
    Nagayama, Satoshi
    Fukunaga, Yosuke
    Kawakami, Kazuyoshi
    Yokokawa, Takashi
    Sugisaki, Takahito
    Ueno, Masashi
    Yamaguchi, Toshiharu
    ANTICANCER RESEARCH, 2018, 38 (03) : 1741 - 1747
  • [7] Phase I study of oxaliplatin in combination with capecitabine and radiotherapy as adjuvant treatment for stage II and III rectal cancer
    Jin, J.
    Li, Y. X.
    Wang, W. H.
    Liu, Y. P.
    Wang, K.
    Fang, H.
    Zhou, Z. X.
    Zhou, A. P.
    Wang, J. W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S284 - S285
  • [8] Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer:: A planned safety analysis in 1,864 patients
    Schmoll, Hans-Joachim
    Cartwright, Thomas
    Tabernero, Josep
    Nowacki, Marek P.
    Figer, Arie
    Maroun, Jean
    Price, Timothy
    Lim, Robert
    Van Cutsem, Eric
    Park, Young-Suk
    McKendrick, Joseph
    Topham, Claire
    Soler-Gonzalez, Gemma
    de Braud, Filipo
    Hill, Mark
    Sirzen, Florin
    Haller, Daniel G.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (01) : 102 - 109
  • [9] Duration of oxaliplatin-based adjuvant chemotherapy in patients with Stage III or high-risk Stage II resected colon cancer
    Moretto, Roberto
    Falcone, Alfredo
    Cremolini, Chiara
    INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (09) : 2652 - 2654
  • [10] FOLFOX for stage II colon cancer? A commentary on the recent FDA approval of oxaliplatin for adjuvant therapy of stage III colon cancer
    Grothey, A
    Sargent, DJ
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (15) : 3311 - 3313
12345